Transplant RCT alert

Tac/mTOR/pred regimen VS tac/MMF/pred regimen in older kidney txp recipients

📌 did not affect graft outcomes
📌 did not increase risk of rejection
📌 did not affect risk of CMV, BK, or skin cancers
📌 more side effects

journals.lww.com/jasn/fulltex...

@nytimes.com has caused some misinformation re organ donation.
Here is a step by step of the real
WHO, WHAT, WHEN, WHY that actually goes into the process of organ donation!
@onelegacy.bsky.social
@ukrocharity.bsky.social
#transplant
#donatelife
#donors
#ukro

Here is a step by step of the
WHO, WHAT, WHEN, WHY that actually goes into the process of organ donation!
(While this is a US centric info graphic , similar processes are used around the globe)

#donationsaveslives
#transplantation

Misinformation about organ donation has surfaced. The truth: it’s a careful, ethical process that saves lives. Nearly 90,000 people wait for a kidney in the US. #DonationSavesLives

Three years at @mayoclinic.org today. Grateful for the incredible colleagues, meaningful work, and the privilege of caring for #transplant patients every day. Here’s to continued growth and impact.

Kidney disease affects 1 in 8 people, and early detection saves lives. Proud to support NKF and all the amazing volunteers making screening possible! @nkf-professionals.bsky.social

#KidneyWalk with the family @mayoclinic.org @nkf-professionals.bsky.social

Our new study from NW Syria about ESKD patients perspective about their care. 29% missed sessions, 60% were displaced, health literacy is low, and many lacked access to nephrologists.

Low-resource solutions are urgently needed.

rdcu.be/elMe8

No one better than Dr. Nada Alachkar to learn from about FSGS & kidney transplant. Great grand rounds @mayoclinic.org Arizona! FSGS post-transplant remains a challenge. Better phenotyping based on permeability factor is key & hopefully we’ll have that capability in coming yrs

congrats to Novartis for receiving FDA approval for iptacopan for C3G. What an amazing era to start having therapies

www.novartis.com/news/media-r...